Literature DB >> 8402000

Twin concordance rates for rheumatoid arthritis: results from a nationwide study.

A J Silman1, A J MacGregor, W Thomson, S Holligan, D Carthy, A Farhan, W E Ollier.   

Abstract

We report the concordance rate for RA in a nationwide study of 91 monozygotic (MZ) and 112 dizygotic (DZ) pairs. Twin pairs were recruited from both a national media campaign and a 2-month prospective inquiry of all UK rheumatologists. Disease status was established following a structured clinical and serological appraisal, together with radiological assessment where necessary. Zygosity was confirmed using DNA fingerprinting. In all, 14 (15.4%) of the MZ and four (3.6%) of the DZ pairs were disease concordant (risk ratio: 4.3 95% CI 1.5 to 12.6). There was no difference in the concordance between the media and clinical derived twins. Further the excess MZ concordance persisted after adjusting for age, age at disease onset, sex and rheumatoid factor status. Analysing the data in relation to the timing of disease onset in the first affected twin showed that subsequent disease risk in the initially unaffected co-twins of the MZ affected probands increased with increasing duration of follow-up. We conclude that the overall MZ concordance at 15% is lower than the 30% figure normally quoted from a study some 30 years ago and sets a ceiling at the potential genetic contribution to disease susceptibility.

Entities:  

Mesh:

Year:  1993        PMID: 8402000     DOI: 10.1093/rheumatology/32.10.903

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  150 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Clinical and immunogenetic characteristics of European multicase rheumatoid arthritis families.

Authors:  A Balsa; P Barrera; R Westhovens; H Alves; K Maenaut; D Pascual-Salcedo; F Cornélis; T Bardin; L Riente; T R Radstake; G de Almeida; V Lepage; C Stravopoulos; M Spaepen; A Lopes-Vaz; D Charron; M Martinez; J F Prudhomme; P Migliorini; P Fritz
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 3.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  Authors respond to criticism of rheumatoid arthritis twin study.

Authors:  Anders Svendsen; Niels V Holm; Kirsten Kyvik; Per Hyltoft Petersen; Peter Junker
Journal:  BMJ       Date:  2002-08-17

Review 5.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 6.  Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?

Authors:  S M Carty; N Snowden; A J Silman
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 7.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

Review 8.  Genetics of Sjögren's syndrome in the genome-wide association era.

Authors:  John A Ice; He Li; Indra Adrianto; Paul Chee Lin; Jennifer A Kelly; Courtney G Montgomery; Christopher J Lessard; Kathy L Moser
Journal:  J Autoimmun       Date:  2012-01-29       Impact factor: 7.094

Review 9.  The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping.

Authors:  Stephen Eyre; Gisela Orozco; Jane Worthington
Journal:  Nat Rev Rheumatol       Date:  2017-06-01       Impact factor: 20.543

10.  New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study.

Authors:  F Cornélis; S Fauré; M Martinez; J F Prud'homme; P Fritz; C Dib; H Alves; P Barrera; N de Vries; A Balsa; D Pascual-Salcedo; K Maenaut; R Westhovens; P Migliorini; T H Tran; A Delaye; N Prince; C Lefevre; G Thomas; M Poirier; S Soubigou; O Alibert; S Lasbleiz; S Fouix; C Bouchier; F Lioté; M N Loste; V Lepage; D Charron; G Gyapay; A Lopes-Vaz; D Kuntz; T Bardin; J Weissenbach
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.